Risk Finance: Pre-Loss and Post-Loss Funding Explained - Chapter 7 Retelling
Book: Structured Finance and Insurance: The ART of Managing Capital and Risk Author: Christopher L. Culp Publisher: Wiley Finance, 2006 ISBN: 978-0-471-70631-1
Chapter 7 is the final chapter of Part One, and it introduces a concept that most people outside the insurance and structured finance world don’t think about much: risk finance. If Chapter 6 was about transferring risk to someone else, Chapter 7 is about keeping the risk but making sure you can survive it.
Here’s the key distinction. With risk transfer, the economic impact of a loss shifts to a counterparty (an insurer, a derivatives counterparty, bondholders). With risk finance, your shareholders still bear the loss. What changes is how you manage the cash flow timing of that loss. Risk finance is about liquidity, not about avoiding losses.
Preloss vs. Postloss Funding
When a firm decides to retain a risk, it has three options for dealing with the potential cash shortfall.
Unfunded retention. Don’t set aside anything. If the loss happens, pay out of pocket from current cash, divert money from planned investments, or issue new securities. This is the cheapest approach when nothing goes wrong. But it can be devastating if the loss is big and the firm can’t easily raise cash.
Preloss funding. Set aside cash before any loss happens. The simplest version is a loss reserve: take $100 million out of current cash and park it in marketable securities. If the loss occurs, you use the reserve. If it doesn’t, you release the reserve or roll it forward.
Culp’s example: a firm faces a potential $100 million loss over the next two years. It issues $100 million in debt up front and holds the proceeds in liquid securities. The net cost is just the spread between the debt interest rate and the investment return on the reserve. If the loss occurs, the cash is ready. If it doesn’t, the firm can call the debt or repurpose the cash.
Postloss funding. Arrange in advance to borrow after a loss occurs, but on terms negotiated before the loss. This is like a put option on your own debt. You pay a commitment fee for the right to borrow at a fixed rate if you need to. If the loss happens, you draw down the facility. If it doesn’t, the commitment fee is your only cost.
The cash flow profiles are different. Preloss funding has a big upfront cash outflow (or a new debt obligation) offset by investment income until the loss occurs. Postloss funding has small ongoing commitment fees with a large potential drawdown later.
M&M Says It Doesn’t Matter
Under M&M assumptions, all three approaches have the same expected funding cost. Culp proves this carefully. Whether you borrow now, borrow later at market rates, or buy an option to borrow later at a fixed rate, the expected cost is the same.
Why? In an M&M world, the firm has unlimited access to capital markets at fair prices. A loss event doesn’t change that. The firm can always borrow at the appropriate rate for its risk level. So prefunding accomplishes nothing that the firm couldn’t do on the spot.
But this is a setup for the real argument. In reality, M&M assumptions don’t hold. And that’s where risk finance starts to matter.
Why Fund a Retention?
Culp identifies three situations where funded retentions add real value.
Preserving Financial Flexibility
Many firms value what they call “financial flexibility,” which is basically excess cash and borrowing capacity held in reserve. It’s the corporate equivalent of keeping some money under the mattress. Not for any specific reason. Just in case.
Funding a retention formalizes this. Instead of a vague “emergency fund,” the firm has a specific reserve tied to a specific risk. This provides comfort. The firm knows that following a major loss, it won’t be scrambling for cash.
If financial flexibility is the only goal, the firm won’t pay much for it. Simple facilities like letters of credit cost just a few basis points. But for firms with lots of intangible assets (where raising traditional debt is already slow and difficult), even this basic level of protection can be worth more than its cost.
Reducing Adverse Selection Costs and Avoiding Cookie Jars
When a firm announces a financial loss, its equity value drops relative to its debt. The firm becomes more leveraged. And from Chapter 4, we know that issuing new securities when you’re already in trouble can be very expensive because of adverse selection.
If the only issue were avoiding adverse selection, the firm could just do a private placement. But there’s something deeper. Firms struggle with credibility. Investors don’t trust that management will use reserves for their stated purpose. A reserve can be reversed at any time for any reason. A letter of credit can be drawn for something totally unrelated to the original risk.
These are “cookie jars.” Places where cash sits with no real guarantee it’ll be used as promised.
True risk finance fixes this. In a properly structured risk financing arrangement, the firm can’t access the funds unless a specific loss event actually occurs. The risk trigger is a binding contractual feature, not a managerial promise. This is very different from a generic reserve that management can reverse whenever it wants.
This credibility element is what distinguishes real risk finance from just having cash sitting around. Lines of credit often contain material adverse change (MAC) clauses that prevent the firm from drawing them precisely when it needs them most (after a big loss has deteriorated the firm’s financial condition). True risk finance facilities are designed to be available exactly in those situations.
Culp makes a strong point here. Risk finance reduces adverse selection costs not just by providing funds, but by strictly conditioning the firm’s leverage on the occurrence of specific risk events. Investors can see that any increase in leverage is tied to a real loss, not to management opportunism.
Mitigating Underinvestment
This is the big one. The Froot, Scharfstein, and Stein (1993) argument shows up again.
Culp illustrates with a chemical firm called Spock. Spock has three possible R&D projects costing EUR 100 million, 200 million, and 400 million, yielding NPVs of EUR 100 million, 800 million, and 50 million respectively. Spock has EUR 250 million in internal funds.
Without any problems, Spock can take on all three projects. But suppose Spock faces a possible chemical spill costing EUR 100 million, and suppose the firm cannot issue new securities after announcing a spill.
If the spill happens, Spock’s available funds drop from EUR 250 million to EUR 150 million. Now it can only afford Projects 1 and 3 (at a cost of EUR 500 million total, which exceeds its budget). The firm is forced to choose Project 1 (the EUR 100 million project with EUR 100 million NPV) plus… wait. Even that’s getting tight. The key point is that Spock might have to pass on Project 2, the EUR 200 million investment that generates EUR 800 million in NPV. That’s a massive value loss, all because the firm’s cash got depleted by an unrelated loss.
Funding the retention of chemical spill risk (either preloss or postloss) guarantees that the EUR 100 million loss won’t eat into the investment budget. The value added comes from the firm’s inability to borrow at fair market prices after a loss. If capital markets were perfect, Spock could just borrow the EUR 100 million after the spill and proceed with all its projects. In reality, it can’t.
Here’s the nuance Culp adds to the standard Froot, Scharfstein, and Stein argument. They argue that risk transfer (hedging, insurance) is the solution to this underinvestment problem. And it is. But Culp points out that it might be more than you need. All that’s actually required is risk finance. You don’t need to eliminate the loss from your balance sheet. You just need to make sure you have the cash to keep investing after the loss hits.
That’s a meaningful distinction. Risk transfer has its own costs. Sometimes all you need is a cash buffer that’s credibly tied to a specific risk, not full risk elimination.
My Take
Chapter 7 is a fitting end to Part One because it brings together the theoretical threads from all previous chapters and shows how they inform a practical decision: should you fund your retained risks, and if so, how?
The cookie jar point resonated with me. It explains why so many corporate reserves and credit facilities don’t actually work as risk management tools. If management can redirect the money at will, investors have no reason to believe the money will be there when it’s needed. The whole point of structured risk finance is to make the commitment credible by tying it to an actual risk event.
The distinction between risk transfer and risk finance is also one of those ideas that seems small at first but keeps getting bigger. Risk transfer is about shifting the economic impact of a loss. Risk finance is about managing the cash flow consequences. Sometimes you need both. Sometimes you only need one. Knowing which is which helps you avoid paying for more protection than you actually need.
Part One is done. We’ve built the theoretical foundation: what capital is, what risk is, how leverage works, how adverse selection affects financing decisions, how capital budgeting works, when risk transfer adds value, and when risk finance can do the job instead.
Starting with Part Two, Culp moves into the traditional tools of risk transfer: insurance, reinsurance, and derivatives. And then in Parts Three and Four, we get to the structured products and ART solutions that are the real point of this book.
The foundation has been laid. Time to build on it.